Navigation Links
Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Date:5/5/2011

d does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About NovartisLocated in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines and diagnostic tools. Novartis is the only company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.us.novartis.com.

# Rapamune® (sirolimus) and Torisel® (temsirolimus) are registered trademarks of Wyeth Pharmaceuticals Inc.

References

  1. Yao, et al. Everolimus for Advanced Pancreatic Neuroendocrine Tumors. New Eng J Med 2011;364:514-23.
  2. Halfdanarson, et al. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Annals of Onc 19: 1727-1733, 2008.
  3. National Library of Medicine and the National Institutes of Health. Pancreatic islet cell tumor. Available at http://www.nlm.nih.gov/medlineplus/ency/article/000393.htm. Accessed April 2011.
  4. Novartis data on file.

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
4. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
5. Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients
6. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
7. Final Approval of Novartis Gender Discrimination Settlement Slated for November 19
8. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Novartis to Expand Global Research Headquarters in Cambridge, MA
11. VIDEO From thenewsmarket.com and Novartis: Phase III Data Show That Novartis Meningococcal Vaccine Menveo® Demonstrated Robust Immunogenicity in Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... June 1, 2015 Researchers from University Hospitals ... Reserve University School of Medicine will present data from ... novel combination treatment for cancer patients with advanced solid ... small cell lung cancer (SCLC), at the 51 st ... in Chicago . ...
(Date:6/1/2015)... LAVAL, QC , June 1, 2015 /CNW Telbec/ -  ... Laval and known under the « Équilibre, ... third quarter Ended on March 31, 2015. All dollar amounts ... Revenues for the third quarter of fiscal year 2015 ... % compared to revenues of $ 3,823,151 for the quarter ...
(Date:6/1/2015)... Women who took vitamin D and calcium supplements ... did not take the supplements, according to a study published ... of the European Menopause and Andropause Society. ... of the Women,s Health Initiative , one of the ... causes of death, disability and impaired quality of life in ...
Breaking Medicine Technology:UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 3Third Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended March 31, 2015 2Third Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended March 31, 2015 3Third Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended March 31, 2015 4Vitamin D and Calcium Supplements Do Not Improve Menopausal Symptoms 2Vitamin D and Calcium Supplements Do Not Improve Menopausal Symptoms 3Vitamin D and Calcium Supplements Do Not Improve Menopausal Symptoms 4
... 17, 2010 The Medical Device practice at,MarketsandMarkets is pleased to announce ... India , China (BRIC) 2010 - 2015. , ... Browse in-depth TOC on Diagnostic ... (BRIC) 2010 - 2015 Market Report. Early buyers will receive 10%,customization of ...
... June 16 Tomorrow, the Food and Drug Administration (FDA) will hold a hearing ... an emergency contraceptive, or a new "Plan B." , ... http://photos.prnewswire.com/prnh/20080930/FRCLOGO ) , , , ... , , ...
Cached Medicine Technology:Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 - 2015: MarketsandMarkets 2Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 - 2015: MarketsandMarkets 3Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 - 2015: MarketsandMarkets 4FRC Urges FDA to Reject New Abortion Drug Falsely Labeled as an Emergency Contraceptive 2
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Lourinda Willey as a 2015-2016 ... Circle. She is recognized with this prestigious distinction for ... is the nation’s leading networking organization exclusively for professional ... operating Local Chapters. , "I’m pleased to present Lourinda ...
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Kathy Everette-Gaines as a 2015-2016 inductee into its ... recognized with this prestigious distinction for leadership in ... exclusively for professional women, boasting more than 700,000 ... “I’m pleased to welcome Kathy into this exceptional ...
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Lenita F. Cornett, DSL, LSSBB (C), ... Inductee into its VIP Woman of the Year Circle. ... in the military. NAPW is the nation's leading networking ... members and over 200 operating Local Chapters. , “I'm ...
(Date:6/1/2015)... Carson Energy also announced they have selected AdvantaIRA ... Trust, LLC is the country’s largest self-directed IRA administrator. ... using IRA’s does 2 things:, 1. It gives investors ... there current cash position will not allow for participation. ... and their investors to be able to participate in ...
(Date:6/1/2015)... New York (PRWEB) June 01, 2015 ... http://www.testosteronelawsuithub.com/ ) has amended the Case Management Order ... AndroGel testosterone gel. The Amended Order which was ... Illinois on May 29, 2015, directs the parties to ... by August 10, 2015 that outlines parameters and the ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4
... Kong health authority had announced on Tuesday that the city ... HIV infections with 89 new cases reported// in the first ... Center for Health Protection under the Department of Health, which ... were related to sexual contact. Reviewing the AIDS situation in ...
... Shimla: The striking medicos, junior doctors and resident doctors ... College Tanda (Kangra),// took out a candle light procession ... central educational institutions. ,The striking medicos and doctors ... units of blood were collected and ran parallel OPDs. ...
... antidepressant Lexapro permitted by Food and Drug Administration, U.S.// ... FDA to sell escitalopram, a generic immitator of the oral ... drug are retained by the Forest Labs till March 2012 ... This copyright is illogical as per Teva. ,Lundbeck, ...
... that if the problem of people having HIV/AIDS as ... measures are not taken//. ,Launching the National ... the director general of Health Services said that the ... the population. "This is probably the reason TB is ...
... found that amino acid, l-cysteine can prevent oral cancers. ... cancers occur// in the mouth, pharynx and oesophagus. The ... results in a strong exposure of the upper digestive ... of Professor Mikko Salaspuro, University of Helsinki and Helsinki ...
... a recent study conducted by researchers at the Washington University ... States it was found// that regular exercise keeps Alzheimer’s at ... signs of the disease but now it is been disproved ... and found that balance problems and a weak handshake are ...
Cached Medicine News:Health News:Finnish research: Cysteine Chewing Gum as a cure for cancers of the mouth 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Severe revision options for the knee and hip...
Severe revision options for the knee and hip...
Medicine Products: